SMT201500156B - Composti di diidropirrolonaftiridinione come inibitori di jak - Google Patents
Composti di diidropirrolonaftiridinione come inibitori di jakInfo
- Publication number
- SMT201500156B SMT201500156B SM201500156T SM201500156T SMT201500156B SM T201500156 B SMT201500156 B SM T201500156B SM 201500156 T SM201500156 T SM 201500156T SM 201500156 T SM201500156 T SM 201500156T SM T201500156 B SMT201500156 B SM T201500156B
- Authority
- SM
- San Marino
- Prior art keywords
- dihydropyrolonaphtoneone
- compounds
- jak inhibitors
- jak
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18515709P | 2009-06-08 | 2009-06-08 | |
| PCT/US2010/037822 WO2010144486A1 (en) | 2009-06-08 | 2010-06-08 | Dihydropyrrolonaphtyridinone compounds as inhibitors of jak |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201500156B true SMT201500156B (it) | 2015-09-07 |
Family
ID=42805991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201500156T SMT201500156B (it) | 2009-06-08 | 2015-07-01 | Composti di diidropirrolonaftiridinione come inibitori di jak |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8420816B2 (pt) |
| EP (1) | EP2440558B1 (pt) |
| JP (1) | JP5719840B2 (pt) |
| CN (1) | CN102459267B (pt) |
| CA (1) | CA2764885C (pt) |
| DK (1) | DK2440558T3 (pt) |
| ES (1) | ES2540964T3 (pt) |
| HK (1) | HK1167654A1 (pt) |
| HR (1) | HRP20150701T1 (pt) |
| HU (1) | HUE026518T2 (pt) |
| PL (1) | PL2440558T3 (pt) |
| PT (1) | PT2440558E (pt) |
| SI (1) | SI2440558T1 (pt) |
| SM (1) | SMT201500156B (pt) |
| WO (1) | WO2010144486A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012078802A1 (en) | 2010-12-08 | 2012-06-14 | Takeda Pharmaceutical Company Limited | PREPARATION OF SUBSTITUTED-4,5-DIHYDROPYRROLO[4,3,2-de][2,6]NAPHTHYRIDIN-3(1H)-ONES |
| KR101433057B1 (ko) * | 2012-03-07 | 2014-09-23 | 한국과학기술원 | 빛에 의해 ｒｔｋ 신호전달을 활성화하는 융합단백질 및 그의 용도 |
| KR101836822B1 (ko) * | 2016-10-17 | 2018-03-09 | 주식회사 엔지켐생명과학 | 모노아세틸디아실글리세롤 화합물을 함유하는 건선의 예방 또는 치료용 조성물 |
| EP3305786A3 (de) | 2018-01-22 | 2018-07-25 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
| WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
| CN110016030B (zh) * | 2019-05-22 | 2021-02-09 | 南京合巨药业有限公司 | 一种5-氟-1H-吡咯-[2,3-b]吡啶-4-甲醛的制备方法 |
| CN112390799B (zh) * | 2019-08-16 | 2022-04-29 | 科岭源生物科技(深圳)有限公司 | 一种含氮杂环类5-ht3受体调节剂及其制备方法和用途 |
| WO2022110052A1 (zh) * | 2020-11-27 | 2022-06-02 | 科岭源生物科技(深圳)有限公司 | 一种含氮杂环类5-ht3受体调节剂及其制备方法和用途 |
| US11561787B2 (en) | 2021-05-13 | 2023-01-24 | International Business Machines Corporation | Application invocation on specified operating system version |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3177299D1 (de) | 1980-04-11 | 1993-04-15 | Ampex | Bildverarbeitungssystem fuer raeumliche bildtransformation. |
| US4437207A (en) | 1982-06-24 | 1984-03-20 | Ross Henry M | Magnetic, force-limited apparatus for tenderizing meat |
| HU187583B (en) | 1983-04-14 | 1986-01-28 | Duna-Tisza Koezi Allami Epitoeipari Vallalat,Hu | Method and apparatus for in-situ producing non-uniform pile from monolithic concrete |
| JPS6054356A (ja) | 1983-09-03 | 1985-03-28 | Taisho Pharmaceut Co Ltd | ３−ベンゾイル−２−メルカプトプロピオン酸誘導体 |
| US4526290A (en) | 1983-10-19 | 1985-07-02 | Ball Corporation | Flanged container |
| EP0193329A3 (en) * | 1985-02-22 | 1987-08-19 | Beecham Group Plc | Pyrazolopyridines, their preparation and pharmaceutical compositions containing them |
| US6600028B1 (en) * | 1997-04-02 | 2003-07-29 | Amersham Pharmacia Biotech Uk Limited | Tricyclic base analogues |
| US6531475B1 (en) | 1998-11-12 | 2003-03-11 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
| EP1129091B1 (en) | 1998-11-12 | 2002-10-02 | Neurocrine Biosciences, Inc. | Crf receptor antagonists and methods relating thereto |
| IL158063A0 (en) | 2001-04-30 | 2004-03-28 | Glaxo Group Ltd | Crf receptor antagonists |
| MXPA03010635A (es) | 2001-05-21 | 2004-12-06 | Sb Pharmco Inc | Derivados de tri- y tetraazaacenaftileno como antagonistas del receptor de crf. |
| GB0117395D0 (en) | 2001-07-17 | 2001-09-05 | Glaxo Group Ltd | Chemical compounds |
| US7273871B2 (en) * | 2001-07-17 | 2007-09-25 | Sb Pharmco Puerto Rico Inc. | Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists |
| US7049303B2 (en) * | 2001-11-07 | 2006-05-23 | Medical Research Council | Inhibition of viruses |
| WO2003061385A1 (en) | 2002-01-17 | 2003-07-31 | Ribapharm Inc. | Tricyclic nucleoside library compounds, synthesis, and use as antiviral agents |
| WO2003087087A2 (en) | 2002-04-09 | 2003-10-23 | Astex Technology Limited | Heterocyclic compounds and their use as modulators of p38 map kinase |
| CA2550361C (en) | 2003-12-19 | 2014-04-29 | Prabha Ibrahim | Compounds and methods for development of ret modulators |
| US20080033172A1 (en) | 2003-12-19 | 2008-02-07 | Koronis Pharmaceuticals, Incorporated | Mutagenic Heterocycles |
| GB0420719D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| EP2251341A1 (en) | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Heterocyclic Janus kinase 3 inhibitors |
| EP2298770A1 (en) * | 2005-11-03 | 2011-03-23 | ChemBridge Corporation | Heterocyclic compounds as TrkA modulators |
| TWI468162B (zh) | 2005-12-13 | 2015-01-11 | 英塞特公司 | 作為傑納斯激酶（ＪＡＮＵＳ ＫＩＮＡＳＥ）抑制劑之經雜芳基取代之吡咯并〔２，３-ｂ〕吡啶及吡咯并〔２，３-ｂ〕嘧啶 |
| JP2009532475A (ja) * | 2006-04-05 | 2009-09-10 | バーテックス ファーマシューティカルズ インコーポレイテッド | ヤヌスキナーゼの阻害剤として有用なデアザプリン |
| GB0619926D0 (en) | 2006-10-09 | 2006-11-15 | Koolmill Systems Ltd | Surface abrasion of objects |
| EP2079740B1 (en) * | 2006-11-01 | 2012-12-05 | Vertex Pharmaceuticals, Inc. | Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| WO2008084861A1 (ja) | 2007-01-12 | 2008-07-17 | Astellas Pharma Inc. | 縮合ピリジン化合物 |
| WO2008100447A2 (en) | 2007-02-09 | 2008-08-21 | Gilead Sciences, Inc. | Nucleoside analogs for antiviral treatment |
| US8329722B2 (en) * | 2007-03-13 | 2012-12-11 | Merck Sharp & Dohme Corp. | Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1 |
| BRPI0809992A2 (pt) * | 2007-04-02 | 2014-10-14 | Palau Pharma Sa | Derivados de pirrolopirimidina |
| CL2008001540A1 (es) | 2007-05-29 | 2009-05-22 | Sgx Pharmaceuticals Inc | Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer. |
| DE602008003055D1 (de) | 2007-05-31 | 2010-12-02 | Nerviano Medical Sciences Srl | Zyklokondensierte Azaindole, die als Kinase-Hemmer wirken |
| WO2009035575A1 (en) * | 2007-09-11 | 2009-03-19 | Merck & Co., Inc. | Inhibitors of janus kinases |
| EP2211620B1 (en) * | 2007-10-25 | 2013-12-25 | Merck Sharp & Dohme Corp. | 3-PYRAZIN SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AS JANUS KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES |
-
2010
- 2010-06-08 DK DK10725338.7T patent/DK2440558T3/en active
- 2010-06-08 HU HUE10725338A patent/HUE026518T2/en unknown
- 2010-06-08 EP EP10725338.7A patent/EP2440558B1/en active Active
- 2010-06-08 CA CA2764885A patent/CA2764885C/en active Active
- 2010-06-08 JP JP2012514236A patent/JP5719840B2/ja active Active
- 2010-06-08 SI SI201030965T patent/SI2440558T1/sl unknown
- 2010-06-08 PL PL10725338T patent/PL2440558T3/pl unknown
- 2010-06-08 WO PCT/US2010/037822 patent/WO2010144486A1/en active Application Filing
- 2010-06-08 ES ES10725338.7T patent/ES2540964T3/es active Active
- 2010-06-08 CN CN201080032853.3A patent/CN102459267B/zh active Active
- 2010-06-08 PT PT107253387T patent/PT2440558E/pt unknown
- 2010-06-08 US US12/796,583 patent/US8420816B2/en active Active
-
2012
- 2012-08-29 HK HK12108435.2A patent/HK1167654A1/xx unknown
-
2013
- 2013-03-06 US US13/787,514 patent/US8785429B2/en active Active
-
2015
- 2015-06-30 HR HRP20150701TT patent/HRP20150701T1/hr unknown
- 2015-07-01 SM SM201500156T patent/SMT201500156B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010144486A1 (en) | 2010-12-16 |
| CN102459267A (zh) | 2012-05-16 |
| CA2764885A1 (en) | 2010-12-16 |
| CN102459267B (zh) | 2014-11-26 |
| EP2440558B1 (en) | 2015-04-01 |
| PT2440558E (pt) | 2015-08-27 |
| PL2440558T3 (pl) | 2015-10-30 |
| US8420816B2 (en) | 2013-04-16 |
| US8785429B2 (en) | 2014-07-22 |
| HK1167654A1 (en) | 2012-12-07 |
| SI2440558T1 (sl) | 2015-10-30 |
| JP5719840B2 (ja) | 2015-05-20 |
| DK2440558T3 (en) | 2015-07-06 |
| HRP20150701T1 (hr) | 2015-08-28 |
| CA2764885C (en) | 2018-05-15 |
| JP2012529437A (ja) | 2012-11-22 |
| US20110136780A1 (en) | 2011-06-09 |
| HUE026518T2 (en) | 2016-06-28 |
| EP2440558A1 (en) | 2012-04-18 |
| US20130184252A1 (en) | 2013-07-18 |
| ES2540964T3 (es) | 2015-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201600291B (it) | Inibitori di proteasi hcv | |
| SMT201700036B (it) | Composti e composizioni come inibitori di protein chinasi | |
| SMT201600267B (it) | Inibitori di syk imidazopirazinici | |
| SMT201600275B (it) | Composti eterociclici utili come inibitori di pdk1 | |
| SMT201600085B (it) | Piperidin-4-il azetidin derivati come inibitori di jak1 | |
| SMT201600075B (it) | Composto di diamminocarbossammide eterociclica | |
| SMT201600008B (it) | Composti di piridazinone | |
| DOP2012000114A (es) | Inhibidor bromodominio de benzodiazepina | |
| SMT201600021B (it) | Nuovi composti di chinolina sostituiti come inibitori della s-nitrosoglutatione reduttasi | |
| SMT201500043B (it) | Indazoli ossazolo-sostituiti come inibitori di pi13-chinasi | |
| SMT201500271B (it) | Inibitori di neprilisina | |
| SMT201500156B (it) | Composti di diidropirrolonaftiridinione come inibitori di jak | |
| SMT201400023B (it) | Analoghi di buprenorfina | |
| CO6960542A2 (es) | Polimorfos de inhibidores de cinasas | |
| SMT201600328B (it) | Nuovi composti come inibitori di diacilglicerolo aciltransferasi | |
| SMT201600001B (it) | Imidazopiridazine come inibitori di akt chinasi | |
| SMT201600031B (it) | Composti eterociclici di fenossimetile | |
| BR112012005382A2 (pt) | inibidores de jak | |
| SMT201500157B (it) | Pirazolilaminopiridine come inibitori di fak | |
| SMT201500268B (it) | Derivato di 5-idrossipirimidin-4-carbossammide | |
| UY33155A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa | |
| DK2506840T3 (da) | Anvendelser af hæmmere af hypoksi-fremkaldende faktorer | |
| DK2453858T3 (da) | Fremgangsmåde | |
| DK2516435T3 (da) | Inhibitorer af AKT-aktivitet | |
| IT1403611B1 (it) | Composizione di poliesteri |